& CO7 e l i m i n a t i o n : (Proximal -P, HI-LO -D). 1793 A l f r e d Krauss,Barbara Lewis,Peter Auld, Cornell Univ. l k d . Colleqe k p t . o f P e d i a t r i c s , New York C i t y . The pressure responie t o mask o c c l u s i o n was measured i n -16 i n f a n t s between 1 and 45 days o f age and 0.9-4.0 k g i n weight. Measurements were made i n a body plethysmograph, a l l o w i n g simultaneous measurements o f pressure responses and l u n g volume(Vtg). A l l i n f a n t s , even t h e l e a s t mature, d e m n s t r a t e d progressive increases i n mask pressure (Pmax) w i t h i n 2-3 breaths a f t e r occlusion. The maximum pressure and the maximum r a t e o f change i n mask pressure ( d p / d t ) were i n v e r s e l y c o r r e l a t e d w i t h Vtg(r=-.35). I n d i v i d u a l i n f a n t s demonstrated a g r e a t e r increase i n pressure w i t h i n 3 breaths a f t e r occlusion w i t h i n c r e a s i n g age i n 6/10 o f p a t i e n t s s t u d i e d on mu1 t i p l e occasions. The degree o f l o a d corn pensation c o r r e l a t e d p o o r l y w i t h Vtg (r=-.26),Vtg/cm (F-.22), and age (r=.24).
Previously published r e s u l t s from t h i s l a b o ra t o r y have d e m n s t r a t e d simultaneous increases i n r e s p i r a t o r y c h e m s e n s i t i v i t y i n conjunction w i t h i n c r e a s i n g m a t u r i t y and i n c r e a s i n g l u n g volume, w h i l e f a i l i n g t o d e t e c t s i g n i f i c a n t vagal e f f e c t s w i t h i n c r e a s i n g lung volume. This i n d i c a t e s t h a t the r o l e o f Vtg i n r e g u l a t i o n o f r e s p i r a t i o n i n t h e newborn i nf a n t i s t o s t a b i l i z e bdood gases and m a i n t a i n normal mechanical aspects o f pulmonary f u n c t i o n . The i n f l u e n c e o f Vtg on the r ef l e x c o n t r o l o f b r e a t h i n g i n h e a l t h y preterm and mature human i n f a n t s i s weak. Impulses a r i s i n g w i t h i n t h e c e n t r a l nervous system and m o d i f i e d by t h e chemreceptors appear t o be the m s t s i g n i f i c a n t source o f r e s p i r a t o r y c o n t r o l i n human neonates. Cnemical) with a mouthpiece attached in the corner. After the bag was inflated and canister activated through the mouthpiece, the patient breathed in and out of tne bag 1U times (through tne mouthpiece).
We compared the bronchodilator efficacy of isoetharine aerosol L puffs (0.34 mg per puff) administered from a MDI in the modified 6 witn 2.5 mg of isoetharine diluted in 2.5 ml of saline nebulized in a compressed air driven J in l;, stable asthmatic children ages 8 to 15. Treatment was given in randomized double blind cross over fashion over a two day period. Pulmonary function was tested before and after therapy for 4 hours. The mean baseline FEVlS were 1.L7 (B) and 1. Beta agonists administered by aerosol are effective treatment for asthma. They produce prompt, significant bronchodiiation. Side effects are few but cardiac arrhythmias may occur when the patient exceeds the prescribed dose. Our previous study (J. Peds 103:635, 1963) showed that 2 puffs of AA did not disturb cardiac rhythm. We have now studied the potential effect of frequently repeated inhalation of AA to simulate the pattern of use by some patients at home. 15 stable outpatient asthmatic children (9 to 14 years old) were treated with 2 puffs of AA (IdUmcg) followed either by hourly placebo or hourly M for 5 hours (10 puffs1900mcgs) in a randomized, double blind cross over study. Cardiac rhythm was Holter monitored and pulmonary function was tested hourly for > hours. Heart rate (HR) was analyzed at hourly intervals. Pretreatment HR of 95bpm declined by l-2bpm after single dose and similarly 2-5bpm from 99bpm during multiple doses. No one developed arrhythmi4 and side effects were infrequent on either day. FEVl increased 35, 38, 42, 41, 44 and 44% above the baseline period at 30, 60, 120, 180, 240 and 300 minutes after multiple doses and 36, 40, 311, 33, 27 and 19% at the same intervals after single dose. Tile difference was significant (P<0.05) at 240 and 300 minutes. No cardiac toxicity occurred with hourly administration (for 5hrs) of AA using MDI. Hence there is apparently a substantial margin of safety in administration of this agent to asthmatic children. Cor pulmonale or right ventricular hypertrophy (RVH) is a recognized complication of BPD, while LVH has been reported mainly at autopsy. Serial cardiac evaluations were performed on 19 infants with BPD during a 2 year period. RVH was documented by EKG and EHCO (RVH=RV wall thickness >2SD above mean predicted) in 13/ 19 infants; 6/19 had an 4 RV dimension and 9/19 had abnormal RV systolic time intervals on at least 1 occasion, suggesting 4 pulmonary artery pressure. 4 LV wall thickness (>2SD above mean) was documented by ECHO in a sub-group of 10 infants. Six of these 10 also had LVH by EKG, and in 7/10 LVH was associated with septa1 hypertrophy. The LVH was present early and resolved in 2, but persisted or increased in 8 over 4 to 24 mnths followup. The characteristics for the 2 groups are summarized: Outcome 2 died, 4 chronic CHF, 2 homeon 02 all home; 5 with O: , All babies required mechanical ventilation from birth; no significant differences were found in maximum Fi02, peak pressure, or in the mean Pa02 achieved during 1st 2 weeks for the 2 groups. Concentric hypertrophy of the LV, documented in a subgroup of BPD infants was associated with a more complicated clinical course, prolonged hospitalization, and a poorer prognosis. 
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